Pomalyst (Pomalidomide) Capsules


Medical Evidence POMALYST

Generic name : Pomalidomide.

Trade name : Pomalyst.

Manufacturer information :

Pomalyst is manufactured by Celgene Corporation.

Pomalyst FDA Approval :

Pomalyst first approved February 8th, 2013.

Pomalyst Dosage form :

Capsules: 1 mg, 2 mg, 3 mg, and 4 mg.


Pomalyst Indications and Usage :

Multiple Myeloma

Thalidomide analogue, in combination with dexamethasone, is indicated for multiple myeloma in patients who have received at least 2 prior therapies (including lenalidomide and a proteasome inhibitor) and have disease progression on or within 60 days of completion of the last therapy.

Pomalyst (Pomalidomide) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.